Pharmalittle: Covid worsened antibiotic resistance; Teva and AbbVie unit settle opioid suit with San Francisco
A top European court issued an antitrust ruling that deals a blow to Illumina''s $7.1 billion acquisition of Grail, a medical testing company.
Pharmalittle: Covid worsened antibiotic resistance; Teva and AbbVie unit settle opioid suit with San Francisco
A top European court issued an antitrust ruling that deals a blow to Illumina''s $7.1 billion acquisition of Grail, a medical testing company.